Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma.

Saved in:
Bibliographic Details
Title: Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma.
Authors: Papathanasiou T; Clinical Pharmacology, Modeling and Simulation, GSK, Baar, Switzerland. theo.x.papathanasiou@gsk.com., Kaullen J; Certara, Radnor, PA, USA., Polireddy K; Certara, Radnor, PA, USA., Chen X; Clinical Pharmacology, Modeling and Simulation, GSK, Collegeville, PA, USA., Ho YL; Clinical Pharmacology, Modeling and Simulation, GSK, Collegeville, PA, USA., Taylor A; Certara, Radnor, PA, USA., Struemper H; Clinical Pharmacology, Modeling and Simulation, GSK, Durham, NC, USA., Carreño F; Clinical Pharmacology, Modeling and Simulation, GSK, Collegeville, PA, USA., Ferron-Brady G; Clinical Pharmacology, Modeling and Simulation, GSK, Collegeville, PA, USA.
Source: Clinical pharmacokinetics [Clin Pharmacokinet] 2025 Jun; Vol. 64 (6), pp. 925-942. Date of Electronic Publication: 2025 May 30.
Publication Type: Journal Article
Journal Info: Publisher: Adis, part of Springer Science+Business Media Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40447948
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Papathanasiou+T%22">Papathanasiou T</searchLink>; Clinical Pharmacology, Modeling and Simulation, GSK, Baar, Switzerland. theo.x.papathanasiou@gsk.com.<br /><searchLink fieldCode="AU" term="%22Kaullen+J%22">Kaullen J</searchLink>; Certara, Radnor, PA, USA.<br /><searchLink fieldCode="AU" term="%22Polireddy+K%22">Polireddy K</searchLink>; Certara, Radnor, PA, USA.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; Clinical Pharmacology, Modeling and Simulation, GSK, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Ho+YL%22">Ho YL</searchLink>; Clinical Pharmacology, Modeling and Simulation, GSK, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Taylor+A%22">Taylor A</searchLink>; Certara, Radnor, PA, USA.<br /><searchLink fieldCode="AU" term="%22Struemper+H%22">Struemper H</searchLink>; Clinical Pharmacology, Modeling and Simulation, GSK, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Carreño+F%22">Carreño F</searchLink>; Clinical Pharmacology, Modeling and Simulation, GSK, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Ferron-Brady+G%22">Ferron-Brady G</searchLink>; Clinical Pharmacology, Modeling and Simulation, GSK, Collegeville, PA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227606849%22">Clinical pharmacokinetics</searchLink> [Clin Pharmacokinet] 2025 Jun; Vol. 64 (6), pp. 925-942. <i>Date of Electronic Publication: </i>2025 May 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+part+of+Springer+Science%2BBusiness+Media%22">Adis, part of Springer Science+Business Media </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>7606849 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1926 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203125963%22">03125963 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacokinet <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40447948
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40262-025-01508-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 925
    Titles:
      – TitleFull: Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Papathanasiou T
      – PersonEntity:
          Name:
            NameFull: Kaullen J
      – PersonEntity:
          Name:
            NameFull: Polireddy K
      – PersonEntity:
          Name:
            NameFull: Chen X
      – PersonEntity:
          Name:
            NameFull: Ho YL
      – PersonEntity:
          Name:
            NameFull: Taylor A
      – PersonEntity:
          Name:
            NameFull: Struemper H
      – PersonEntity:
          Name:
            NameFull: Carreño F
      – PersonEntity:
          Name:
            NameFull: Ferron-Brady G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1926
          Numbering:
            – Type: volume
              Value: 64
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Clinical pharmacokinetics
              Type: main
ResultId 1